3.08 pm | 11 Feb 2012 |  Source: Moneycontrol.com

Sushil Finance is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 368 in its February 9, 201...

2.48 pm | 02 Feb 2012 |  Source: Moneycontrol.com

Nirmal Bang has recommended hold rating on Glenmark Pharma with a target of Rs 364, in its February 1, 2012 research report....

11.35 am | 02 Feb 2012 |  Source: Moneycontrol.com

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 360 in its February 1, 2012 research report....

11.21 am | 01 Feb 2012 |  Source: Moneycontrol.com

PINC Research is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 343 in its January 30, 2012 researc...

8.57 am | 01 Feb 2012 |  Source: CNBC-TV18

After the powerful rally we had yesterday, Sudarshan Sukhani of s2analytics.com says that it is bet not to question the wisdom of the market and go lo...

6.47 pm | 31 Jan 2012 |  Source: Moneycontrol.com

Glenmark Pharma has reported a sales turnover of Rs 399.22 crore and a net profit of Rs 13.14 crore for the quarter ended Dec '11...

1.18 pm | 31 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Praful Borah of Nirmal Bang Institutional Equities speak about Glenmark, Divi's results and gives his outlook going forw...

8.20 am | 31 Jan 2012 |  Source: CNBC-TV18

Glenmark Pharma has reported a profit after tax of Rs 46 crore in the third quarter of FY12, a fall of 47% as compared to Rs 86.5 crore in a year ago ...

8.13 am | 31 Jan 2012 |  Source: CNBC-TV18

SBI | PNB | ICICI Bank | Glenmark | Lupin | Electrotherm | Edelweiss Capital | KNR Constructions | Tata Global Beverages | Coal India and Gujarat Gas ...

9.59 am | 30 Jan 2012 |  Source: CNBC-TV18

Glenmark Pharma is expected to report a profit after tax of Rs 106 crore in the third quarter of FY12, rising 89% as compared to Rs 56 crore in previo...

6.11 pm | 24 Jan 2012 |  Source: CNBC-TV18

SP Tulsian, sptulsian.com shares his view on Strides Arcolab and he says that the deal is positive for the company....

9.02 pm | 19 Jan 2012 |  Source: PTI

Pharma major Glenmark Pharmaceuticals today said it has appointed Sandeep Gupta as Chief Operating Officer (COO) and Michael Buschle as Chief Scientif...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

6.20 pm | 11 Jan 2012 |  Source: Moneycontrol.com

KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

2.19 pm | 14 Dec 2011 |  Source: Moneycontrol.com

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 360 in its December 13, 2011 research report....

1.57 pm | 14 Dec 2011 |  Source: Moneycontrol.com

PINC Research is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 345 in its December 13, 2011 resear...

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...

2.57 pm | 21 Nov 2011 |  Source: Moneycontrol.com

Nirmal Bang has recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 358, in its November 18, 2011 research report....

7.03 pm | 10 Nov 2011 |  Source: Moneycontrol.com

Glenmark Pharma has reported a sales turnover of Rs 382.72 crore and a net profit of Rs 31.46 crore for the quarter ended Sep '11...